APA (7th ed.) Citation

Chovi-Trull, M., Ñungo-Garzón, N. C., Aragon-Gawinska, K. A., Pitarch-Castellano, I., Albert-Marí, A., García-Pellicer, J., . . . Vázquez-Costa, J. F. (2026). Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study. Neurology & Therapy, 1. https://doi.org/10.1007/s40120-026-00947-7

Chicago Style (17th ed.) Citation

Chovi-Trull, Maria, Nancy C. Ñungo-Garzón, Karolina A. Aragon-Gawinska, Inmaculada Pitarch-Castellano, Asunción Albert-Marí, Javier García-Pellicer, José L. Poveda-Andrés, María D. Edo-Solsona, and Juan F. Vázquez-Costa. "Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study." Neurology & Therapy 2026: 1. https://doi.org/10.1007/s40120-026-00947-7.

MLA (9th ed.) Citation

Chovi-Trull, Maria, et al. "Adherence, Persistence, and Safety of Risdiplam in Spinal Muscular Atrophy: A Population-Based Cohort Study." Neurology & Therapy, 2026, p. 1, https://doi.org/10.1007/s40120-026-00947-7.